From the FDA Drug Label
The FDA drug label does not answer the question.
From the Research
I strongly support disability benefits for this patient due to their severe medical conditions that significantly impair daily functioning. The patient suffers from worsening uncontrolled rheumatoid arthritis causing debilitating bilateral hand pain and stiffness, along with similar symptoms in the back, shoulders, and knees. This condition alone severely limits their ability to perform instrumental activities of daily living (IADLs). Additionally, the patient has uncontrolled diabetes and hypertension, which further compromise their health status and functional capacity. Some key points to consider in the management of rheumatoid arthritis include the use of disease-modifying antirheumatic drugs (DMARDs) like methotrexate, as discussed in studies such as 1, which highlights best practices for methotrexate use in RA patients, including the importance of high initial doses and rapid titration to improve response. However, without financial access to these medications, the patient's condition continues to deteriorate. The combination of uncontrolled diabetes and hypertension further increases the risk of serious complications including cardiovascular disease, stroke, kidney damage, and neuropathy, as would be a concern in managing patients with multiple chronic conditions. Disability benefits would provide the financial support necessary for this patient to access appropriate medical care, afford essential medications, and potentially improve their quality of life and functional status. Key considerations in the treatment of rheumatoid arthritis, such as those outlined in 2, which discusses drug combinations with methotrexate, are crucial but are hindered by the patient's inability to afford necessary treatments. Given the potential for methotrexate to have beneficial effects on blood pressure and arterial function, as suggested by studies like 3, access to this medication could be particularly beneficial for this patient with uncontrolled hypertension. However, the primary concern remains the patient's immediate need for financial support to access medical care and improve their quality of life, given the severe impact of their uncontrolled medical conditions on their daily functioning.